VerImmune Inc. raised $4.5 million in a Pre-Series A financing round led by Beiley Biofund to advance its Virus-inspired Particle (ViP™) platform technology.
Amount Raised
$4.5 Million
Round Type
Pre-Series A
BaltimoreBiotechnologyInvestors
Description
VerImmune Inc. has successfully completed the first closing of its Pre-Series A financing round, raising $4.5 million to further develop its innovative ViP-based therapeutics. The round was led by Beiley Biofund, with participation from various other investors, including returning supporters.
Quick answer
VerImmune raised $4.5 Million in a Pre-Series A round, dated September 23, 2024. Investors: Gaingels, Dr. John Ballantyne, Proxima Ventures, Mana Ventures and Beiley Biofund. VerImmune is based in Baltimore, Maryland, United States.
- How much did VerImmune raise?
- VerImmune raised $4.5 Million in a Pre-Series A round on September 23, 2024.
- Who invested in VerImmune?
- Gaingels, Dr. John Ballantyne, Proxima Ventures, Mana Ventures and Beiley Biofund are named as investors in this round.
- What does VerImmune do?
- VerImmune is biotechnology company developing a novel first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR).
- Where is VerImmune based and how big is it?
- VerImmune is based in Baltimore, Maryland, United States.
- Who are the decision-makers at VerImmune?
- Fundz holds 2 contacts at VerImmune, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as VerImmune that raised within 45 days of this round, from Fundz verified event records.
- Cytonics Corp raised $8.3M (Seed) on November 7, 2024.
- Acelot raised $8.7M (Seed) on November 7, 2024.
- Geron raised $375M (Debt Financing) on November 7, 2024.
- Nexstem raised $3.5M (Seed) on November 7, 2024.
- EdenRoc Sciences raised $2.8M (Seed) on November 7, 2024.
- TRex Bio raised $42M on November 7, 2024.
Who to call at VerImmune, and when
A new round usually means VerImmune is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VerImmune raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VerImmune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VerImmune. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VerImmune raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
VerImmune raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.